HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Xiao Selected Research

nootkatone

4/2021Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury.
12/2019Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
9/2018Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer's disease.
1/2018Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Xiao Research Topics

Disease

31Neoplasms (Cancer)
04/2022 - 08/2007
17Inflammation (Inflammations)
01/2022 - 01/2007
11Infections
01/2021 - 07/2012
10Cognitive Dysfunction
11/2020 - 11/2002
8Stomach Neoplasms (Stomach Cancer)
07/2021 - 11/2009
6Myocardial Infarction
08/2021 - 06/2012
6Breast Neoplasms (Breast Cancer)
01/2021 - 08/2011
5Sepsis (Septicemia)
10/2021 - 05/2016
5Nasopharyngeal Carcinoma
01/2021 - 01/2012
5Wounds and Injuries (Trauma)
01/2020 - 01/2003
5Alzheimer Disease (Alzheimer's Disease)
01/2020 - 09/2018
4Rheumatoid Arthritis
06/2022 - 07/2008
4Experimental Arthritis
06/2022 - 05/2011
4Neoplasm Metastasis (Metastasis)
04/2022 - 08/2015
4Squamous Cell Carcinoma of Head and Neck
04/2022 - 01/2013
4Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2020
4Glioma (Gliomas)
01/2022 - 03/2007
4Reperfusion Injury
01/2021 - 04/2012
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2011
4Arthritis (Polyarthritis)
11/2020 - 05/2011
4Carcinogenesis
01/2020 - 01/2016
4Carcinoma (Carcinomatosis)
01/2020 - 01/2008
4Brain Edema (Cerebral Edema)
10/2004 - 02/2002
3Liver Neoplasms (Liver Cancer)
04/2022 - 04/2019
3Hemorrhage
03/2022 - 01/2016
3Pain (Aches)
01/2022 - 01/2009
3COVID-19
10/2021 - 01/2021
3Stroke (Strokes)
08/2021 - 03/2014
3Neuroinflammatory Diseases
04/2021 - 11/2014
3Lung Injury
01/2021 - 01/2003
3Hypoxia (Hypoxemia)
01/2021 - 01/2016
3Fibrosis (Cirrhosis)
01/2021 - 05/2011
3Necrosis
01/2021 - 01/2017
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 05/2017
3Acute Kidney Injury (Acute Renal Failure)
07/2020 - 10/2009
3Diarrhea
01/2019 - 01/2016
3Pneumonia (Pneumonitis)
10/2016 - 10/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016 - 05/2011
3Hypothermia
04/2016 - 02/2002
3Brain Ischemia (Cerebral Ischemia)
03/2014 - 05/2004
3Aneurysm (Aneurysms)
12/2013 - 02/2007
3Liver Diseases (Liver Disease)
05/2011 - 01/2008
3Spinal Cord Injuries (Spinal Cord Injury)
09/2008 - 02/2008
2Epilepsy (Aura)
02/2022 - 04/2021
2Periodontitis
01/2022 - 04/2021
2Chronic Kidney Failure (Chronic Renal Failure)
11/2021 - 02/2011
2Chronic Renal Insufficiency
11/2021 - 07/2020
2Cytopenia
06/2021 - 01/2008
2Hyperammonemia
04/2021 - 04/2021
2Seizures (Absence Seizure)
04/2021 - 05/2015
2Obesity
01/2021 - 01/2020
2Brain Neoplasms (Brain Tumor)
01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
10Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2009
9CytokinesIBA
04/2021 - 03/2007
7Messenger RNA (mRNA)IBA
01/2022 - 01/2008
6Biological ProductsIBA
01/2022 - 08/2015
6InflammasomesIBA
01/2021 - 01/2017
5Methotrexate (Mexate)FDA LinkGeneric
06/2022 - 07/2008
5Long Noncoding RNAIBA
01/2022 - 01/2021
5Therapeutic UsesIBA
04/2021 - 07/2008
5Pharmaceutical PreparationsIBA
04/2020 - 03/2014
5Polysaccharides (Glycans)IBA
02/2020 - 05/2019
5Neuroprotective AgentsIBA
12/2019 - 11/2002
5Small Interfering RNA (siRNA)IBA
08/2015 - 08/2006
4Phosphotransferases (Kinase)IBA
04/2022 - 03/2007
4nootkatoneIBA
04/2021 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2021 - 11/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2017
4Blood Glucose (Blood Sugar)IBA
01/2021 - 05/2015
4Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020 - 01/2017
4Triglycerides (Triacylglycerol)IBA
05/2019 - 01/2008
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 12/2018
3salicylhydroxamic acid (SHAM)IBA
01/2020 - 10/2004
3Immunoglobulin G (IgG)IBA
01/2020 - 05/2011
3MicroRNAs (MicroRNA)IBA
01/2020 - 01/2017
3Collagen Type II (Type II Collagen)IBA
08/2019 - 07/2008
3Gefitinib (Iressa)FDA Link
10/2016 - 05/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 01/2007
2EnzymesIBA
05/2022 - 11/2019
2Matrix Metalloproteinases (MMPs)IBA
04/2022 - 09/2002
2C-Reactive ProteinIBA
02/2022 - 01/2009
2Oxygen (Dioxygen)IBA
01/2022 - 01/2021
2NitrogenIBA
01/2022 - 05/2015
2IronIBA
10/2021 - 01/2021
2AntioxidantsIBA
04/2021 - 05/2019
2schizandrinIBA
04/2021 - 12/2019
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2021 - 10/2016
2CatalaseIBA
04/2021 - 01/2018
2Alanine Transaminase (SGPT)IBA
04/2021 - 10/2016

Therapy/Procedure

18Therapeutics
04/2022 - 01/2008
14Radiotherapy
01/2021 - 05/2011
10Drug Therapy (Chemotherapy)
01/2020 - 05/2011
6Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2021 - 11/2002
4Resuscitation
11/2004 - 09/2002
3Immunotherapy
01/2022 - 02/2018
3Length of Stay
07/2020 - 10/2009
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2013 - 01/2012
2Artificial Respiration (Mechanical Ventilation)
08/2021 - 07/2020
2Craniotomy
01/2021 - 08/2018